These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36704248)

  • 1. The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson's disease.
    Smith JK; Mellick GD; Sykes AM
    Front Cell Neurosci; 2022; 16():1081426. PubMed ID: 36704248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central theme of Parkinson's disease: α-synuclein.
    Ozansoy M; Başak AN
    Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease].
    Qiao S; Luo JH; Jin JH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):210-4. PubMed ID: 22499522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
    Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
    FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons.
    Goloborshcheva VV; Kucheryanu VG; Voronina NA; Teterina EV; Ustyugov AA; Morozov SG
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.
    Yu Z; Xu X; Xiang Z; Zhou J; Zhang Z; Hu C; He C
    PLoS One; 2010 Apr; 5(4):e9956. PubMed ID: 20386702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents.
    Sato H; Kato T; Arawaka S
    Mol Neurobiol; 2015 Aug; 52(1):226-35. PubMed ID: 25143237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.
    Wakabayashi K; Tanji K; Mori F; Takahashi H
    Neuropathology; 2007 Oct; 27(5):494-506. PubMed ID: 18018486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
    Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
    Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.
    Recasens A; Carballo-Carbajal I; Parent A; Bové J; Gelpi E; Tolosa E; Vila M
    Acta Neuropathol Commun; 2018 Feb; 6(1):8. PubMed ID: 29422109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance.
    Cui H; Wang W; Zheng X; Xia D; Liu H; Qin C; Tian H; Teng J
    J Mol Neurosci; 2021 Dec; 71(12):2500-2513. PubMed ID: 33772424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-Synuclein Aggregation in Parkinson's Disease.
    Srinivasan E; Chandrasekhar G; Chandrasekar P; Anbarasu K; Vickram AS; Karunakaran R; Rajasekaran R; Srikumar PS
    Front Med (Lausanne); 2021; 8():736978. PubMed ID: 34733860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers and the Role of α-Synuclein in Parkinson's Disease.
    Du T; Wang L; Liu W; Zhu G; Chen Y; Zhang J
    Front Aging Neurosci; 2021; 13():645996. PubMed ID: 33833675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.